# A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump

> **NCT07068295** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 65 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** NNC0471-0119 H
- **DRUG:** Insulin Aspart

## Key facts

- **NCT ID:** NCT07068295
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-11
- **Primary completion:** 2026-02-22
- **Final completion:** 2026-03-10
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07068295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07068295, "A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07068295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*